~~<i id='F5B1098D82'><strike id='F5B1098D82'><tt id='F5B1098D82'><pre id='F5B1098D82'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

Wikipedia

author：leisure time 2025-10-01 21:35:37 - browse：41173

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： Secretariat’s lessons for human medicine

leisure time

Wikipedia

leisure time

hotspot

focus

JohnMoore/GettyImagesIntheUnitedStates,morethan1.6millionpeopleidentifyastransgender.Ofthese,moretha

WSS

FDA advisory panel to debate high blood pressure devices

Meadows told special counsel he could not recall Trump ever declassifying Mar

Congress may force more Covid

California store owner shot dead in dispute over displaying Pride flag: Police

How to make over

New study raises questions about niacin and heart health

focus

Wikipedia

leisure time

Affirmative action in medical school literally saved lives

Intellia plays down concerns on accidental germline transmission

Jerome Adams on the need for new antivirals for Covid

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Medicare proposal to cover medical devices draws a mixed reaction

Listen: Vivek Ramaswamy's star turn & leaky drug data

ChatGPT in medicine: STAT answers readers' burning questions

Wegovy improves function in certain heart failure patients

Medicare details structure of new drug price negotiation program

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

leisure time

Study: Spinal cord stimulation helps patients with paralysis walk again

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

Surprise medical billing ban raises prices elsewhere

Flagship Pioneering startup Sonata Therapeutics lays off 21

How the first Native Hawaiian psychiatrist helped diversify medicine

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Wikipedia

leisure time

hotspot

focus